loadpatents
name:-0.18020701408386
name:-0.067464113235474
name:-0.0036489963531494
Harbeson; Scott L. Patent Filings

Harbeson; Scott L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Harbeson; Scott L..The latest application filed is for "deuterated derivatives of ruxolitinib".

Company Profile
2.65.90
  • Harbeson; Scott L. - Cambridge MA
  • Harbeson; Scott L. - Lexington MA
  • Harbeson; Scott L - Cambridge MA
  • Harbeson; Scott L. - Cincinnati OH
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Deuterated Derivatives Of Ruxolitinib
App 20210330674 - Silverman; I. Robert ;   et al.
2021-10-28
Deuterated OTX-015
Grant 10,683,305 - Harbeson , et al.
2020-06-16
Deuterated Derivatives Of Ruxolitinib
App 20190308976 - Silverman; I. Robert ;   et al.
2019-10-10
Inhibitors of the enzyme UDP-glucose: N-acyl-sphingosine glucosyltransferase
Grant 10,385,042 - Harbeson A
2019-08-20
Substituted triazolobenzodiazepines
Grant 10,357,499 - Harbeson July 23, 2
2019-07-23
Substituted xanthine derivatives
Grant 10,335,413 - Tung , et al.
2019-07-02
Substituted Xanthine Derivatives
App 20180333417 - Tung; Roger D. ;   et al.
2018-11-22
Substituted Triazolobenzodiazepines
App 20180303848 - Harbeson; Scott L.
2018-10-25
Deuterated Otx-015
App 20180298028 - Harbeson; Scott L. ;   et al.
2018-10-18
Substituted triazolobenzodiazepines
Grant 10,039,769 - Harbeson August 7, 2
2018-08-07
Deuterated pyrazino[2,1-a]isoquinoline compounds and methods of treatment using the same
Grant 9,944,635 - Liu , et al. April 17, 2
2018-04-17
Inhibitors Of The Enzyme Udp-glucose: N-acyl-sphingosine Glucosyltransferase
App 20180086743 - Harbeson; Scott L.
2018-03-29
Substituted xanthine derivatives
Grant 9,918,987 - Tung , et al. March 20, 2
2018-03-20
Deuterated Emricasan
App 20180044375 - Harbeson; Scott L.
2018-02-15
Inhibitors of the enzyme UDP-glucose: N-acyl-sphingosine glucosyltransferase
Grant 9,783,528 - Harbeson October 10, 2
2017-10-10
Substituted Triazolobenzodiazepines
App 20170258807 - Harbeson; Scott L.
2017-09-14
Deuterated Derivatives Of Ruxolitinib
App 20170239254 - Silverman; I. Robert ;   et al.
2017-08-24
Substituted triazolobenzodiazepines
Grant 9,694,017 - Harbeson July 4, 2
2017-07-04
Substituted thienotriazolodiazapines
Grant 9,676,790 - Harbeson June 13, 2
2017-06-13
Substituted Xanthine Derivatives
App 20170027946 - Tung; Roger D. ;   et al.
2017-02-02
Substituted Triazolobenzodiazepines
App 20160346296 - Harbeson; Scott L.
2016-12-01
Substituted xanthine derivatives
Grant 9,493,463 - Tung , et al. November 15, 2
2016-11-15
Substituted xanthine derivatives
Grant 9,492,457 - Tung , et al. November 15, 2
2016-11-15
Synthesis of deuterated morpholine derivatives
Grant 9,453,009 - Liu , et al. September 27, 2
2016-09-27
Substituted Thienotriazolodiazapines
App 20160214995 - Harbeson; Scott L.
2016-07-28
Substituted xanthine derivatives
Grant 9,328,113 - Tung , et al. May 3, 2
2016-05-03
Pyrazinoisoquinoline Compounds
App 20160083385 - Liu; Julie F. ;   et al.
2016-03-24
Inhibitors Of The Enzyme Udp-glucose: N-acyl-sphingosine Glucosyltransferase
App 20160068519 - Harbeson; Scott L.
2016-03-10
Pyrazinoisoquinoline Compounds
App 20160060263 - Liu; Julie F. ;   et al.
2016-03-03
Deuterated derivatives of ruxolitinib
Grant 9,249,149 - Silverman , et al. February 2, 2
2016-02-02
Deuterated Pacritinib
App 20160009732 - Harbeson; Scott L.
2016-01-14
Methods of use comprising deuterated pyrazino[2,1-a]isoquinolines
Grant 9,206,179 - Liu , et al. December 8, 2
2015-12-08
Deuterated pyrazino[2,1-a]isoquinolines for the treatment of diseases and/or conditions
Grant 9,199,986 - Liu , et al. December 1, 2
2015-12-01
Substituted Xanthine Derivatives
App 20150322068 - Tung; Roger D. ;   et al.
2015-11-12
Substituted Xanthine Derivatives
App 20150272956 - Tung; Roger D. ;   et al.
2015-10-01
Deuterated Derivatives of Ruxolitinib
App 20150239896 - Silverman; I. Robert ;   et al.
2015-08-27
Deuterated Derivatives Of Ruxolitinib
App 20150197525 - Silverman; I. Robert ;   et al.
2015-07-16
Pyrazinoisoquinoline Compounds
App 20150141431 - Liu; Julie F. ;   et al.
2015-05-21
Substituted xanthine derivatives
Grant 9,035,050 - Tung , et al. May 19, 2
2015-05-19
Substituted Xanthine Derivatives
App 20150119407 - Tung; Roger D. ;   et al.
2015-04-30
Substituted Triazolo-pyridazine Derivatives
App 20150111895 - Harbeson; Scott L.
2015-04-23
Synthesis Of Deuterated Morpholine Derivatives
App 20150099714 - Liu; Julie F. ;   et al.
2015-04-09
Substituted triazolo-pyridazine derivatives
Grant 8,993,570 - Harbeson , et al. March 31, 2
2015-03-31
Deuterium-substituted xanthine derivatives and methods of use
Grant 8,987,442 - Tung , et al. March 24, 2
2015-03-24
Substituted xanthine derivatives
Grant 8,952,016 - Tung , et al. February 10, 2
2015-02-10
Substituted triazolo-pyridazine derivatives
Grant 8,921,366 - Harbeson December 30, 2
2014-12-30
Deuterated pyrazinoisoquinoline compounds
Grant 8,889,687 - Liu , et al. November 18, 2
2014-11-18
Analogues of cilostazol
Grant 8,765,723 - Persichetti , et al. July 1, 2
2014-07-01
Substituted Xanthine Derivatives
App 20140121226 - Tung; Roger D. ;   et al.
2014-05-01
Pyrazinoisoquinoline Compounds
App 20140107127 - Liu; Julie F. ;   et al.
2014-04-17
Substituted Triazolophthalazine Derivatives
App 20140024652 - Harbeson; Scott L.
2014-01-23
Substituted Triazolo-pyridazine Derivatives
App 20130317033 - Harbeson; Scott L. ;   et al.
2013-11-28
Deuterated darunavir
Grant 8,592,487 - Harbeson November 26, 2
2013-11-26
Synthesis Of Deuterated Morpholine Derivatives
App 20130281456 - Liu; Julie F. ;   et al.
2013-10-24
Deuterated pyrazinoisoquinoline compounds
Grant 8,563,554 - Liu , et al. October 22, 2
2013-10-22
Substituted triazolophthalazine derivatives
Grant 8,557,815 - Harbeson October 15, 2
2013-10-15
Substituted Triazolo-pyridazine Derivatives
App 20130225590 - Harbeson; Scott L.
2013-08-29
Substituted triazolo-pyridazine derivatives
Grant 8,501,738 - Harbeson , et al. August 6, 2
2013-08-06
Analogues Of Cilostazol
App 20130131021 - Persichetti; Rose A. ;   et al.
2013-05-23
N-phenyl-2-pyrimidineamine Derivatives
App 20130121963 - Harbeson; Scott L. ;   et al.
2013-05-16
Fluorinated diaryl urea derivatives
Grant 8,410,082 - Liu , et al. April 2, 2
2013-04-02
Substituted triazolo-pyridazine derivatives
Grant 8,399,467 - Harbeson March 19, 2
2013-03-19
Azapeptide Derivatives
App 20130041156 - Harbeson; Scott L. ;   et al.
2013-02-14
Pyrazinoisoquinoline Compounds
App 20130029997 - Liu; Julie F. ;   et al.
2013-01-31
Synthesis of deuterated morpholine derivatives
Grant 8,354,557 - Liu , et al. January 15, 2
2013-01-15
Inhibitors Of Serine Proteases, Particularly Hepatitis C Virus Ns3 Protease
App 20130012430 - Tung; Roger D. ;   et al.
2013-01-10
Analogues of cilostazol
Grant 8,349,817 - Persichetti , et al. January 8, 2
2013-01-08
Substituted Diphenylpyrazine Derivatives
App 20130005742 - Harbeson; Scott L. ;   et al.
2013-01-03
Pyrimidinecarboxamide derivatives
Grant 8,318,754 - Harbeson November 27, 2
2012-11-27
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
Grant 8,314,141 - Tung , et al. November 20, 2
2012-11-20
Prostacyclin Derivatives
App 20120270934 - Masse; Craig E. ;   et al.
2012-10-25
Substituted benzimidazoles
Grant 8,278,460 - Liu , et al. October 2, 2
2012-10-02
Fluorinated Diaryl Urea Derivatives
App 20120237474 - Liu; Julie F. ;   et al.
2012-09-20
Deuterium substituted xanthine derivatives
Grant 8,263,601 - Tung , et al. September 11, 2
2012-09-11
Azapeptide derivatives
Grant 8,258,309 - Harbeson , et al. September 4, 2
2012-09-04
Substituted Xanthine Derivatives
App 20120202830 - Tung; Roger D. ;   et al.
2012-08-09
Azapeptide Derivatives
App 20120165288 - Harbeson; Scott L. ;   et al.
2012-06-28
Pyrazinoisoquinoline Compounds
App 20120149709 - Liu; Julie F. ;   et al.
2012-06-14
1,2-benzisoxazol-3-yl compounds
Grant 8,198,305 - Harbeson June 12, 2
2012-06-12
Azapeptide derivatives
Grant 8,158,805 - Harbeson , et al. April 17, 2
2012-04-17
Substituted Triazolo-pyridazine Derivatives
App 20120004236 - Harbeson; Scott L.
2012-01-05
Deuterated Pyridinones
App 20110313004 - Harbeson; Scott L.
2011-12-22
Endothelin receptor antagonists
Grant 8,080,549 - Harbeson December 20, 2
2011-12-20
Endothelin receptor antagonists
Grant 8,071,596 - Harbeson December 6, 2
2011-12-06
Prostacyclin Analogs
App 20110294815 - Harbeson; Scott L.
2011-12-01
Hydroxyethlamino Sulfonamide Derivatives
App 20110257111 - Harbeson; Scott L. ;   et al.
2011-10-20
4-oxoquinoline derivatives
Grant 7,994,194 - Harbeson August 9, 2
2011-08-09
Substituted Benzimidazoles
App 20110172280 - Liu; Julie F. ;   et al.
2011-07-14
Substituted Triazolophthalazine Derivatives
App 20110172235 - Harbeson; Scott L.
2011-07-14
Deuterated Tizanidine
App 20110160253 - Harbeson; Scott L.
2011-06-30
Anti-anginal compounds
Grant 7,943,620 - Harbeson , et al. May 17, 2
2011-05-17
Deuterium Bearing Analogs Of Anastrozole As Aromatase Inhibitors For The Treatment Of Breast Cancer
App 20110104158 - Harbeson; Scott L.
2011-05-05
Substituted Imidazotriazines
App 20110082147 - Harbeson; Scott L. ;   et al.
2011-04-07
Substituted Xanthine Derivatives
App 20110077255 - Tung; Roger D. ;   et al.
2011-03-31
Substituted Triazolo-pyridazine Derivatives
App 20110065711 - Harbeson; Scott L. ;   et al.
2011-03-17
Substituted Xanthine Derivatives
App 20110059995 - Tung; Roger D. ;   et al.
2011-03-10
Substituted Xanthine Derivatives
App 20110053961 - Tung; Roger D. ;   et al.
2011-03-03
Azapeptide Derivatives
App 20110009355 - Harbeson; Scott L. ;   et al.
2011-01-13
Hydroxyethylamino Sulfonamide Derivatives
App 20100305173 - Harbeson; Scott L. ;   et al.
2010-12-02
Tetrahydrotriazolopyrazine derivatives and uses thereof
Grant 7,820,666 - Harbeson October 26, 2
2010-10-26
Analogues Of Cilostazol
App 20100249079 - Persichetti; Rose A. ;   et al.
2010-09-30
N-phenyl-2-pyrimidineamine Derivatives
App 20100221221 - Harbeson; Scott L. ;   et al.
2010-09-02
Synthesis of deuterated morpholine derivatives
App 20100160247 - Liu; Julie F. ;   et al.
2010-06-24
Novel Pyrimidinecarboxamide Derivatives
App 20100152214 - Harbeson; Scott L.
2010-06-17
Deuterated darunavir
App 20100113589 - Harbeson; Scott L.
2010-05-06
Pyrimidinecarboxamide derivatives
Grant 7,687,509 - Harbeson March 30, 2
2010-03-30
Endothelin receptor antagonists
App 20100063076 - Harbeson; Scott L.
2010-03-11
Substituted xanthine derivatives
App 20090239886 - Tung; Roger D. ;   et al.
2009-09-24
Anchor-Assisted Fragment Selection and Directed Assembly
App 20090163371 - Stern; Andrew M. ;   et al.
2009-06-25
Inhibitors Of Serine Proteases, Particularly Hepatitis C Virus Ns3 Protease
App 20090143312 - Tung; Roger D. ;   et al.
2009-06-04
4-Oxoquinoline derivatives
App 20090143427 - Harbeson; Scott L.
2009-06-04
Pyrimidinedione derivatives
App 20090137457 - Harbeson; Scott L.
2009-05-28
Deuterated darunavir
App 20090131363 - Harbeson; Scott L.
2009-05-21
Substituted morpholinyl compounds
Grant 7,528,131 - Persichetti , et al. May 5, 2
2009-05-05
Novel Pyrimidinecarboxamide Derivatives
App 20090035324 - Harbeson; Scott L.
2009-02-05
Azapeptide derivatives
App 20090036357 - Harbeson; Scott L. ;   et al.
2009-02-05
Endothelin receptor antagonists
App 20090005394 - Harbeson; Scott L.
2009-01-01
Anti-anginal compounds
App 20080318969 - Harbeson; Scott L. ;   et al.
2008-12-25
Tetrahydrotriazolopyrazine Derivatives And Uses Thereof
App 20080280913 - Harbeson; Scott L.
2008-11-13
Substituted morpholinyl compounds
App 20080261983 - Persichetti; Rose A. ;   et al.
2008-10-23
Selective endothelin type-a antagonists
App 20080262006 - Harbeson; Scott L.
2008-10-23
1,2-Benzisoxazol-3-yl Compounds
App 20080255194 - Harbeson; Scott L.
2008-10-16
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
Grant 7,388,017 - Tung , et al. June 17, 2
2008-06-17
Heteroaryl Compounds Useful As Inhibitors Of Gsk-3
App 20070270420 - Harbeson; Scott L. ;   et al.
2007-11-22
Inhibitors of p38
Grant 7,271,181 - Green , et al. September 18, 2
2007-09-18
Inhibitors of JAK protein kinase
Grant 7,271,179 - Bemis , et al. September 18, 2
2007-09-18
Aminofurazan compounds useful as protein kinase inhibitors
Grant 7,157,476 - Come , et al. January 2, 2
2007-01-02
Aminofurazan compounds useful as protein kinase inhibitors
App 20050148640 - Come, Jon H. ;   et al.
2005-07-07
Amino-alkyl derivatives
App 20050065339 - Harbeson, Scott L. ;   et al.
2005-03-24
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
App 20040266731 - Tung, Roger D. ;   et al.
2004-12-30
Inhibitors of Jak protein kinase
App 20040038992 - Bemis, Guy W. ;   et al.
2004-02-26
Heteroaryl compounds useful as inhibitors of GSK-3
App 20040034037 - Harbeson, Scott L. ;   et al.
2004-02-19
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
Grant 6,617,309 - Tung , et al. September 9, 2
2003-09-09
Inhibitors of p38
App 20030096817 - Green, Jeremy ;   et al.
2003-05-22
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
App 20020032175 - Tung, Roger D. ;   et al.
2002-03-14
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
Grant 6,265,380 - Tung , et al. July 24, 2
2001-07-24
Cyclic Antiplatelet peptides with pseudo-bond
Grant 6,107,275 - Harbeson , et al. August 22, 2
2000-08-22
Neurokinin A antagonists
Grant 5,830,863 - Buck , et al. November 3, 1
1998-11-03
Optically pure calpain inhibitor compounds
Grant 5,541,290 - Harbeson , et al. July 30, 1
1996-07-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed